NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Cardiol Therapeutics Inc. Class A Common Shares Share Price Chart

O H L

Cardiol Therapeutics Inc. Class A Common Shares Performance Overview

Days Range
$1.86Low
$1.90High

Markets Today

Previous Close$1.86
Open$1.89
Volume583,635
Day's Range$1.86 - $1.90
52W Range$0.88 - $2.34
Market Cap$229.25 M

Historical Performance

1M Returns-1.85
3M Returns+75.47
6M Returns+88.47
1Y Returns+67.57
5Y Returns-57.34
10Y ReturnsNA

Cardiol Therapeutics Inc. Class A Common Shares Fundamentals

Market Cap$229.25 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
RevenueN/A
ROE TTMN/A
EPS TTM$-0.24
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDAN/A
Profit MarginN/A
Market Cap$229.25 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
RevenueN/A
ROE TTMN/A
EPS TTM$-0.24
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDAN/A
Profit MarginN/A

Cardiol Therapeutics Inc. Class A Common Shares Return Calculator

The Cardiol Therapeutics Inc. Class A Common Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$4,220
Invested Amount$10,000
Est. Returns$-5,780
Invest in USA Stock Today

About Cardiol Therapeutics Inc. Class A Common Shares

Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.

FAQs

Cardiol Therapeutics Inc. Class A Common Shares (CRDL) share price as of September 18, 2026 is $1.84. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Cardiol Therapeutics Inc. Class A Common Shares (CRDL) Share by opening an international trading account with Angel One.
Purchasing Cardiol Therapeutics Inc. Class A Common Shares (CRDL) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Cardiol Therapeutics Inc. Class A Common Shares (CRDL) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Cardiol Therapeutics Inc. Class A Common Shares (CRDL) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Cardiol Therapeutics Inc. Class A Common Shares on September 18, 2026, is $229.25 M.
Cardiol Therapeutics Inc. Class A Common Shares operates in the null sector, specifically in the null industry.
In order to invest in Cardiol Therapeutics Inc. Class A Common Shares (CRDL) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91